Align Technology (ALGN) Jefferies Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
Jefferies Global Healthcare Conference 2026 summary
4 Jun, 2026Macro environment and business outlook
International markets are experiencing double-digit growth, especially in APAC, EMEA, and Latin America, while North America shows stability but faces retail-side pressure.
Guidance for the year includes 3%-4% revenue growth and a 100 basis point operating margin improvement, reflecting ongoing cost actions and productivity gains.
Sequential revenue growth from Q1 to Q2 is expected to be more modest (midpoint of 1%) due to prudent guidance amid ongoing macro uncertainty.
Cost actions and increased volume are driving operating margin leverage, with a 250 basis point improvement ex-FX in Q1.
The company feels well-positioned for the year, executing strategies despite an uncertain environment.
Product innovation and rollout
The comprehensive product with no refinements is being rolled out broadly, targeting orthodontists and DSOs, with full rollout expected by year-end.
This product is designed to compete with wires and brackets, offering price competitiveness and high gross margins due to fewer refinements.
Early adoption among DSOs has led to increased utilization, and similar trends are emerging among retail accounts.
Flexibility in product offerings, such as the 3-and-3 plan, allows doctors to choose service levels, supporting adoption.
Gross margins are equal to or better in DSOs compared to retail, with operational efficiencies contributing to higher operating margins.
Tools and programs to drive conversion
Financing programs like HFD and Smile Advance, offering low down payments and 0% APR, are helping drive patient conversion, with over 6,000 offices enrolled.
These programs benefit both patients (affordability) and doctors (upfront cash flow), with high acceptance rates and support from DSOs.
Adoption is faster in DSOs due to top-down implementation, but retail doctors are also being targeted with support and education.
Financing is more common among general dentists than orthodontists, but both segments are being addressed to drive conversion.
Visualization tools and active sales support help doctors convert interested patients into treatments.
Latest events from Align Technology
- Record Q2 2026 revenue and Clear Aligner growth offset Systems & Services softness and UK VAT charge.ALGN
Q2 20265 Aug 2026 - Product innovation and digital adoption drive global growth and margin expansion across key regions.ALGN
Leerink Global Healthcare Conference 202617 Jul 2026 - Q2 2025 saw sequential revenue growth but year-over-year decline and major restructuring plans.ALGN
Q2 20259 Jul 2026 - Clear Aligner volume up 6.2% YoY, revenue down 1.8%; margin, volume growth expected in 2025.ALGN
Q1 20258 Jul 2026 - Record Q4 and FY2025 results, robust Clear Aligner growth, and strong 2026 outlook.ALGN
Q4 20258 Jul 2026 - Record 2024 revenues and volumes set the stage for 2025 growth despite FX headwinds.ALGN
Q4 20248 Jul 2026 - Flexible pricing, new financing, and direct fab innovation drive growth amid mixed regional trends.ALGN
Baird Global Healthcare Conference 20258 Jul 2026 - International growth, product innovation, and digital adoption drive double-digit gains and margin expansion.ALGN
Goldman Sachs 47th Annual Global Healthcare Conference 20268 Jun 2026 - AI-powered digital workflows and 3D printing are transforming orthodontic care and patient engagement.ALGN
46th Annual William Blair Growth Stock Conference3 Jun 2026